82707-05-9

Basic information

• Product Name: methyl 3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside
• Synonyms: methyl 3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside
• CAS NO: 82707-05-9
• Molecular Weight: 280.364
• Mol File: 82707-05-9.mol

Chemical Properties

• CAS DataBase Reference: methyl 3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside(82707-05-9)
• EPA Substance Registry System: methyl 3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside(82707-05-9)

Safety Data

• Hazardous Substances Data: 82707-05-9(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 81076-89-3 1,6-anhydro-2,4-didesoxy-2,4-di-C-methyl-3-O-benzyl-β-D-glucopyranose 
• 76690-23-8 (1S,2S,3S,4R,5R)-2,4-Dimethyl-6,8-dioxabicyclo<3.2.1>octan-3-ol 
• 85433-12-1 (1S,2S,3S,4S,5R)-2-Methyl-3,4-epoxy-6,8-dioxabicyclo<3.2.1>octan-3-ol 
• 85433-11-0 (1S,2S,3S,4R,5R)-2-methyl-4-<(p-toluenesulfonyl)-oxy>-6,8-dioxabicyclo<3.2.1>octan-3-ol 
• 101978-79-4 Methyl 4,6-O-benzylidene-2-deoxy-2-C-methyl-α-D-allopyranoside 
• 194149-26-3 methyl 2,3:4,6-di-O-benzylidene-α-D-mannopyranoside 
• 220094-47-3 (2R,3S,4S,5R,6S)-2-(tert-Butyl-diphenyl-silanyloxymethyl)-6-methoxy-5-methyl-tetrahydro-pyran-3,4-diol 
• 75879-81-1 Methyl 4,6-O-Benzylidene-2-deoxy-2-C-methyl-α-D-allopyranoside 
• 82731-53-1 (2S,4R,5R,6S)-2-Hydroxymethyl-6-methoxy-3,5-dimethyl-tetrahydro-pyran-4-ol 
• 100-39-0 benzyl bromide 
• 220094-48-4 Dimethyl-carbamic acid (2R,3R,4S,5R,6S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-3-chloro-6-methoxy-5-methyl-tetrahydro-pyran-4-yl ester 
• 220094-49-5 tert-Butyl-((1S,2R,4S,5R,6S)-4-methoxy-5-methyl-3,7-dioxa-bicyclo[4.1.0]hept-2-ylmethoxy)-diphenyl-silane 
• 82707-13-9 methyl 3-O-acetyl-4,6-O-benzylidene-2-C-methyl-α-D-allopyranoside 

Downstream Products

• 82707-14-0 methyl 6-aldehydo-3-O-benzyl-2,4-dideoxy-2,4-di-C-methyl-α-D-gulopyranoside 
• 162189-47-1 (S)-1-((2S,3R,4R,5R,6S)-4-Benzyloxy-6-methoxy-3,5-dimethyl-tetrahydro-pyran-2-yl)-3-(tert-butyl-dimethyl-silanyl)-prop-2-yn-1-ol 
• 162189-48-2 [(S)-3-((2S,3R,4R,5R,6S)-4-Benzyloxy-6-methoxy-3,5-dimethyl-tetrahydro-pyran-2-yl)-3-methoxy-prop-1-ynyl]-tert-butyl-dimethyl-silane 
• 82707-15-1 (2S,3S,4S,5R)-3-Benzyloxy-2,4-dimethyl-heptane-1,5-diol 
• 82769-13-9 methyl 3-O-benzyl-2,4,6,7-tetradeoxy-2,4-di-C-methyl-α-D-gulo-heptopyranoside 
• 82768-70-5 methyl 3-O-benzyl-2,4,6,7-tetradeoxy-2,4-di-C-methyl-α-D-gulo-hept-6-enopyranoside 
• 82707-16-2 (3R,4S,6S)-5-Benzyloxy-4,6-dimethyl-7-trityloxy-heptan-3-ol 
• 82707-06-0 (4R,6S)-5-Benzyloxy-4,6-dimethyl-7-trityloxy-heptan-3-one 
• 82707-10-6 (2S,3S,6S,7S,8S,9S)-8-Benzyloxy-1-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methoxy-3,5,7,9-tetramethyl-10-trityloxy-decane-4,6-diol 
• 82707-09-3 (2S,3S,4R,8S,9S)-3-Benzyloxy-10-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-7-hydroxy-9-methoxy-2,4,6,8-tetramethyl-1-trityloxy-decan-5-one 
• 82707-09-3 (2S,3S,4R,6S,7R,8S,9S)-3-Benzyloxy-10-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-7-hydroxy-9-methoxy-2,4,6,8-tetramethyl-1-trityloxy-decan-5-one 
• 82707-09-3 (2S,3S,4R,6R,7S,8S,9S)-3-Benzyloxy-10-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-7-hydroxy-9-methoxy-2,4,6,8-tetramethyl-1-trityloxy-decan-5-one 
• 92268-68-3 ((2S,3R,4R,5R,6S)-4-Benzyloxy-6-methoxy-3,5-dimethyl-tetrahydro-pyran-2-yl)-{2-[(1R,2S)-3-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methoxy-1-methyl-propyl]-[1,3]dithian-2-yl}-methanone 
• 82707-06-0 3-O-benzyl-2,4,6,7-tetradeoxy-5-keto-2,4-di-C-methyl-1-O-triphenylmethyl-L-lyxo-heptitol 

Relevant articles and documents

Total synthesis of soraphen A(1α)

The convergent synthesis of macrolide soraphen A(1α) is described starting from glucose (western part) and mannose (eastern part). Mannose was converted into a 2-deoxyribohexopyranoside that could be methylated and reduced stereoselectively. Chain elongation at C-6 was carried out by stereoselective addition of a magnesium acctylide. The two fragments (western and eastern) were assembled by a Julia olefination followed by macrolactonization. The introduction of the methyl group at C-2 of norsoraphen occurred stereoselectively for thermodynamic reasons.

THE OXIRANE RING OPENINGS OF THE DIANHYDRO SUGAR WITH HIGH REGIOSELETIVITY AND ITS USE IN PREPARATION OF TWO CHIRAL SEGMENTS OF 6-DEOXYERYTHRONOLIDE B

The oxirane ring of the dianhydro sugar 2 obtained from levoglucosan (1,6-anhydro-β-D-glucose) is opened regioselectively with organometallic carbon nucleophiles and its application to an asymmetric synthesis of the C1-C5 segment 9 t

ASSEMBLY OF THE C19-C29 ALIPHATIC SEGMENT OF RIFAMYCIN S FROM D-DLUCOSE BY THE CHIRON APPROACH

We describe a stereocontrolled method for the construction of the aliphatic chain of rifamycin S, based on a strategy that utilizes carbohydrates as optically active precursors.